GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

SRI

Top section

Top section

Sabadell achieves 'super-strong' senior appearance

◆ Spanish issuer funds with no new issue premium, if not breaching through fair value ◆ Market shows approval of the lone senior FIG print ◆ 'No major impact' spotted from BBVA's takeover expectations
There is no crock of equity gold at the end of the rainbow

La Française des Jeux hits jackpot with bond debut

M&A refinancing wins more than €11bn of orders and tightens by 50bp

'Frustration' after South Africa snubs local banks for Eurobond

There was no clear reason why local banks were not picked, sources said, for first time in 17 years
There is no crock of equity gold at the end of the rainbow
Sub-sections
  • AstraZeneca, the UK drug maker, hit the euro market on Wednesday after printing $7bn across the Atlantic a day earlier. The borrower is building up funds to pay for its $39bn acquisition of US rival Alexion Pharmaceuticals.
  • UnitedHealth Group finally sealed its $7bn merger and acquisition-related bond deal after a week-long delay, but it was stung by secondary market volatility as inflation fears remained top of investor minds.
  • Official and multilateral lenders are taking a lenient stance on perennial defaulter Argentina but bond investors are increasingly sceptical whether the IMF programme that the sovereign says it wants will turn its fiscal position around. Markets are pricing in another default within a few years, despite a rebound in bonds this week, while eccentric policy decisions continue to frustrate bondholders.